Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Chitosan-based systems for intranasal immunization against foot-and-mouth disease.

Çokçalışkan C, Özyörük F, Gürsoy RN, Alkan M, Günbeyaz M, Arca HÇ, Uzunlu E, Şenel S.

Pharm Dev Technol. 2014 Mar;19(2):181-8. doi: 10.3109/10837450.2013.763263. Epub 2013 Feb 4.

PMID:
23379822
2.

Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.

Pan L, Zhang Z, Lv J, Zhou P, Hu W, Fang Y, Chen H, Liu X, Shao J, Zhao F, Ding Y, Lin T, Chang H, Zhang J, Zhang Y, Wang Y.

Int J Nanomedicine. 2014 Dec 2;9:5603-18. doi: 10.2147/IJN.S72318. eCollection 2014.

3.

Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.

Tajdini F, Amini MA, Mokarram AR, Taghizadeh M, Azimi SM.

Pharm Dev Technol. 2014 May;19(3):333-41. doi: 10.3109/10837450.2013.784335. Epub 2013 Apr 16.

PMID:
23590209
4.

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.

Wang G, Pan L, Zhang Y, Wang Y, Zhang Z, Lü J, Zhou P, Fang Y, Jiang S.

PLoS One. 2011;6(11):e27605. doi: 10.1371/journal.pone.0027605. Epub 2011 Nov 15.

5.

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.

Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, Wang B.

Vaccine. 2008 Sep 19;26(40):5135-44. doi: 10.1016/j.vaccine.2008.03.088. Epub 2008 May 6.

PMID:
18462848
6.

Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.

Bhat SA, Saravanan P, Hosamani M, Basagoudanavar SH, Sreenivasa BP, Tamilselvan RP, Venkataramanan R.

Res Vet Sci. 2013 Dec;95(3):1217-23. doi: 10.1016/j.rvsc.2013.07.007. Epub 2013 Aug 19.

PMID:
23969204
7.

Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine.

Barrette RW, Szczepanek SM, Rood D, Challa S, Avery N, Vajdy M, Kramer E, Rodriguez L, Silbart LK.

Clin Vaccine Immunol. 2011 Nov;18(11):1996-8. doi: 10.1128/CVI.05273-11. Epub 2011 Sep 14.

8.

Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.

Guo HC, Sun SQ, Jin Y, Yang SL, Wei YQ, Sun DH, Yin SH, Ma JW, Liu ZX, Guo JH, Luo JX, Yin H, Liu XT, Liu DX.

Vet Res. 2013 Jul 4;44:48. doi: 10.1186/1297-9716-44-48.

9.

Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.

Balamurugan V, Renji R, Venkatesh G, Reddy GR, Nair SP, Ganesh K, Suryanarayana VV.

Arch Virol. 2005 May;150(5):967-79. Epub 2005 Jan 19.

PMID:
15662485
10.

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.

Grubman MJ.

Biologicals. 2005 Dec;33(4):227-34. Epub 2005 Nov 14.

PMID:
16289996
11.

Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.

Batista A, Quattrocchi V, Olivera V, Langellotti C, Pappalardo JS, Di Giacomo S, Mongini C, Portuondo D, Zamorano P.

Vaccine. 2010 Aug 31;28(38):6361-6. doi: 10.1016/j.vaccine.2010.06.098. Epub 2010 Jul 14.

PMID:
20637310
12.

Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.

Dar PA, Ganesh K, Nagarajan G, Sarika S, Reddy GR, Suryanarayana VV.

Scand J Immunol. 2012 Oct;76(4):345-53. doi: 10.1111/j.1365-3083.2012.02733.x.

13.

Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.

Blignaut B, Visser N, Theron J, Rieder E, Maree FF.

J Gen Virol. 2011 Apr;92(Pt 4):849-59. doi: 10.1099/vir.0.027151-0. Epub 2010 Dec 22.

PMID:
21177923
14.

Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.

Eblé PL, Bouma A, Weerdmeester K, Stegeman JA, Dekker A.

Vaccine. 2007 Jan 22;25(6):1043-54. Epub 2006 Oct 9.

PMID:
17157418
15.

An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus.

Nanda RK, Edao BM, Hajam IA, Sekar SC, Ganesh K, Bhanuprakash V, Kishore S.

Virol Sin. 2012 Dec;27(6):373-6. doi: 10.1007/s12250-012-3269-2. Epub 2012 Dec 28. No abstract available.

PMID:
23271578
16.

Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs.

Nanda RK, Hajam IA, Edao BM, Ramya K, Rajangam M, Chandra Sekar S, Ganesh K, Bhanuprakash V, Kishore S.

Biologicals. 2014 May;42(3):153-9. doi: 10.1016/j.biologicals.2014.01.002. Epub 2014 Mar 20.

PMID:
24656961
17.

Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.

Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G.

Vaccine. 2013 Jul 18;31(33):3327-32. doi: 10.1016/j.vaccine.2013.05.078. Epub 2013 Jun 2.

PMID:
23735678
18.
19.

Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.

Du Y, Dai J, Li Y, Li C, Qi J, Duan S, Jiang P.

Vet Immunol Immunopathol. 2008 Aug 15;124(3-4):274-83. doi: 10.1016/j.vetimm.2008.04.011. Epub 2008 Apr 22.

PMID:
18511133
20.

An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.

Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.

Vaccine. 2013 Apr 26;31(18):2302-9. doi: 10.1016/j.vaccine.2013.02.060. Epub 2013 Mar 13.

PMID:
23499593

Supplemental Content

Support Center